NSEStatement of deviation(s) or variation(s) under Reg. 326d ago · 13 Aug 2026, 07:06 pm
Statement of deviation(s) or variation(s) under Reg. 32
Innovana Thinklabs Limited · INNOVANA
✦ AI SummaryResults
Innovana Thinklabs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 regarding the use of proceeds from the preferential issue of 8,60,000 warrants.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Innovana Thinklabs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
Attachments (1)
📄pdf
Download →
INNOVANA_13082026190605_StofDeviation.pdf
View document text
Date: August 13, 2026
The General Manager The General Manager
Department of Corporate Services, Department of Corporate Services,
BSE Limited National Stock Exchange of India Limited
Phiroze Jee Jee Bhoy Tower Exchange Plaza, Bandra Kural Complex,
Dalal Street, Fort Mumbai – 400001 Bandra (East), Mumbai – 400051
Scrip Code: 544302 Trading Symbol: INNOVANA
Subject: Statement of deviation(s) or variation(s) in the use of proceeds of allotment of warrants on
preferential basis under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“SEBI Listing Regulations”)
Dear Sir/Ma’am,
Pursuant to Regulation 32 of the SEBI Listing Regulations, read with relevant SEBI Circulars, it is hereby
confirmed that there is no deviation or variation in the use of proceeds from the preferential issue of
8,60,000 (Eight Lakhs Sixty Thousand) warrants, each convertible into, or exchangeable for, one fully
paid-up equity share of the Company of face value of Rs. 10/- each at a price of Rs. 431/- each
(including the warrant subscription price and the warrant exercise price) from the objects as stated in
the explanatory statement to the Notice of the Extra Ordinary General Meeting dated June 27, 2025.
A statement confirming that there is no deviation or variation in the utilization of these proceeds, for
the quarter ended June 30, 2026, duly reviewed and approved by the Audit Committee at its Meeting
held on August 13, 2026 is enclosed as Annexure I.
We request you to take the afore-mentioned information in record and oblige.
Thanking you,
Yours faithfully,
For Innovana Thinklabs Limited
Vasu Ajay Anand
Company Secretary & Compliance Officer
Annexure I
Statement on deviation / variation in utilisation of funds raised
Name of listed entity Innovana Thinklabs Limited
Mode of Fund Raising Preferential Issue of Convertible Warrants
Date of Raising Funds 05-09-2025
Amount Raised The minimum amount of Rs. 9,26,65,000/- (Rupees Nine Crore
Twenty Six Lakh Sixty Five Thousand only), which is equivalent to
25% (twenty five percent) of the Warrants Issue Price was paid at
the time of subscription and allotment of each Warrant (“Warrant
Subscription Amount”). Further, the Warrant holders will be
required to make further payments of Rs. 27,79,95,000/- (Rupees
Twenty-seven Crores Seventy-nine lakhs ninety-five thousand
only), which is equivalent to the balance 75% (seventy five
percent) of the Warrants Issue Price at the time of exercise of the
right attached to the Warrant(s), to subscribe to equity share(s) of
the Company (“Warrant Exercise Amount”). Out of Rs.
27,79,95,000, the Company received Rs. 5,17,20,000 on 13th
October, 2025 pursuant to conversion of 1,60,000 warrants into
equity shares of the Company. (Refer Note 1)
Report filed for Quarter ended 30.06.2026
Monitoring Agency applicable / not applicable
Monitoring Agency Name, if NA
applicable
Is there a Deviation / Variation in No
use of funds raised
If yes, whether the same is NA
pursuant to change in terms of a
contract or objects, which was
approved by the shareholders
If Yes, Date of shareholder NA
Approval
Explanation for the Deviation / NA
Variation
Comments of the Audit The Committee observed that there are no deviations or
Committee after review variations in the utilization of issue proceeds from the stated
objects.
Comments of the auditors, if any -
Objects for which funds have been raised and where there has been a deviation, in the following table
Original Modified Original Modified Funds Amount of Remarks if
Object Object, if Allocation allocation, Utilised Deviation/Variation any
any if any for the quarter
according to
applicable object
General NA Rs. 0 0 No -
Corporate 14,43,85,000/-
Purposes
Deviation or variation could mean:
(a) Deviation in the objects or purposes for which the funds have been raised or
(b) Deviation in the amount of funds actually utilized as against what was originally disclosed or
(c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer,
etc.
Note:
As of September 5, 2025, the Company had received Rs. 9,26,65,000 out of the total issue proceeds of
Rs. 37,06,60,000. During the quarter ended December 31, 2025, 1,60,000 warrants were exercised by
the warrant holders and hence, the Company received Rs. 5,17,20,000 as Warrant Exercise Amount
on October 13,2025. Consequently, the total issue proceeds received by the Company as of December
31, 2025 was Rs. 14,43,85,000. The remaining Rs 22,62,75,000 is expected to be received by the
Company within 18 months from the date of allotment of the share warrants.
Thanking You,
Yours faithfully
For Innovana Thinklabs Limited
Vasu Ajay Anand
Company Secretary & Compliance Officer